131 related articles for article (PubMed ID: 9186560)
1. Antimicrobial activity of viridiofungins.
Onishi JC; Milligan JA; Basilio A; Bergstrom J; Curotto J; Huang L; Meinz M; Nallin-Omstead M; Pelaez F; Rew D; Salvatore M; Thompson J; Vicente F; Kurtz MB
J Antibiot (Tokyo); 1997 Apr; 50(4):334-8. PubMed ID: 9186560
[TBL] [Abstract][Full Text] [Related]
2. Viridiofungins, novel inhibitors of sphingolipid synthesis.
Mandala SM; Thornton RA; Frommer BR; Dreikorn S; Kurtz MB
J Antibiot (Tokyo); 1997 Apr; 50(4):339-43. PubMed ID: 9186561
[TBL] [Abstract][Full Text] [Related]
3. Discovery, biosynthesis, and mechanism of action of the zaragozic acids: potent inhibitors of squalene synthase.
Bergstrom JD; Dufresne C; Bills GF; Nallin-Omstead M; Byrne K
Annu Rev Microbiol; 1995; 49():607-39. PubMed ID: 8561474
[TBL] [Abstract][Full Text] [Related]
4. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity.
Dawson MJ; Farthing JE; Marshall PS; Middleton RF; O'Neill MJ; Shuttleworth A; Stylli C; Tait RM; Taylor PM; Wildman HG
J Antibiot (Tokyo); 1992 May; 45(5):639-47. PubMed ID: 1624366
[TBL] [Abstract][Full Text] [Related]
5. Aspergillus flavus squalene synthase as an antifungal target: Expression, activity, and inhibition.
Song J; Shang N; Baig N; Yao J; Shin C; Kim BK; Li Q; Malwal SR; Oldfield E; Feng X; Guo RT
Biochem Biophys Res Commun; 2019 May; 512(3):517-523. PubMed ID: 30904161
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory activity to protein prenylation and antifungal activity of zaragozic acid D3, a potent inhibitor of squalene synthase produced by the fungus, Mollisia sp. SANK 10294.
Tanimoto T; Ohya S; Tsujita Y
J Antibiot (Tokyo); 1998 Apr; 51(4):428-31. PubMed ID: 9630865
[TBL] [Abstract][Full Text] [Related]
7. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. II. Structure elucidation.
Sidebottom PJ; Highcock RM; Lane SJ; Procopiou PA; Watson NS
J Antibiot (Tokyo); 1992 May; 45(5):648-58. PubMed ID: 1624367
[TBL] [Abstract][Full Text] [Related]
8. Zaragozic acids D and D2: potent inhibitors of squalene synthase and of Ras farnesyl-protein transferase.
Dufresne C; Wilson KE; Singh SB; Zink DL; Bergstrom JD; Rew D; Polishook JD; Meinz M; Huang L; Silverman KC
J Nat Prod; 1993 Nov; 56(11):1923-9. PubMed ID: 8289063
[TBL] [Abstract][Full Text] [Related]
9. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. III. Biosynthesis.
Jones CA; Sidebottom PJ; Cannell RJ; Noble D; Rudd BA
J Antibiot (Tokyo); 1992 Sep; 45(9):1492-8. PubMed ID: 1429235
[TBL] [Abstract][Full Text] [Related]
10. The squalestatins: decarboxy and 4-deoxy analogues as potent squalene synthase inhibitors.
Chan C; Andreotti D; Cox B; Dymock BW; Hutson JL; Keeling SE; McCarthy AD; Procopiou PA; Ross BC; Sareen M; Scicinski JJ; Sharratt PJ; Snowden MA; Watson NS
J Med Chem; 1996 Jan; 39(1):207-16. PubMed ID: 8568810
[TBL] [Abstract][Full Text] [Related]
11. Competitive inhibition of squalene synthetase by squalestatin 1.
Hasumi K; Tachikawa K; Sakai K; Murakawa S; Yoshikawa N; Kumazawa S; Endo A
J Antibiot (Tokyo); 1993 Apr; 46(4):689-91. PubMed ID: 8501015
[No Abstract] [Full Text] [Related]
12. Comparative study of the inhibition of rat and tobacco squalene synthase by squalestatins.
Fulton DC; Tait M; Threlfall DR
Phytochemistry; 1995 Mar; 38(5):1137-41. PubMed ID: 7766395
[TBL] [Abstract][Full Text] [Related]
13. Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase.
Bergstrom JD; Kurtz MM; Rew DJ; Amend AM; Karkas JD; Bostedor RG; Bansal VS; Dufresne C; VanMiddlesworth FL; Hensens OD
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):80-4. PubMed ID: 8419946
[TBL] [Abstract][Full Text] [Related]
14. The ergosterol biosynthesis inhibitor zaragozic acid promotes vacuolar degradation of the tryptophan permease Tat2p in yeast.
Daicho K; Maruyama H; Suzuki A; Ueno M; Uritani M; Ushimaru T
Biochim Biophys Acta; 2007 Jul; 1768(7):1681-90. PubMed ID: 17531951
[TBL] [Abstract][Full Text] [Related]
15. Production of additional squalestatin analogues by directed biosynthesis.
Cannell RJ; Dawson MJ; Hale RS; Hall RM; Noble D; Lynn S; Taylor NL
J Antibiot (Tokyo); 1994 Feb; 47(2):247-9. PubMed ID: 8150722
[No Abstract] [Full Text] [Related]
16. The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analogues.
Procopiou PA; Cox B; Kirk BE; Lester MG; McCarthy AD; Sareen M; Sharratt PJ; Snowden MA; Spooner SJ; Watson NS; Widdowson J
J Med Chem; 1996 Mar; 39(7):1413-22. PubMed ID: 8691471
[TBL] [Abstract][Full Text] [Related]
17. Total synthesis of the squalene synthase inhibitor zaragozic acid C by a carbonyl ylide cycloaddition strategy.
Nakamura S; Hirata Y; Kurosaki T; Anada M; Kataoka O; Kitagaki S; Hashimoto S
Angew Chem Int Ed Engl; 2003 Nov; 42(43):5351-5. PubMed ID: 14613174
[No Abstract] [Full Text] [Related]
18. Massive production of farnesol-derived dicarboxylic acids in mice treated with the squalene synthase inhibitor zaragozic acid A.
Vaidya S; Bostedor R; Kurtz MM; Bergstrom JD; Bansal VS
Arch Biochem Biophys; 1998 Jul; 355(1):84-92. PubMed ID: 9647670
[TBL] [Abstract][Full Text] [Related]
19. Bisabosquals, novel squalene synthase inhibitors. I. Taxonomy, fermentation, isolation and biological activities.
Minagawa K; Kouzuki S; Nomura K; Yamaguchi T; Kawamura Y; Matsushima K; Tani H; Ishii K; Tanimoto T; Kamigauchi T
J Antibiot (Tokyo); 2001 Nov; 54(11):890-5. PubMed ID: 11827030
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of squalene synthase and squalene epoxidase in tobacco cells triggers an up-regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase.
Wentzinger LF; Bach TJ; Hartmann MA
Plant Physiol; 2002 Sep; 130(1):334-46. PubMed ID: 12226513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
